tiprankstipranks
Ultragenyx Pharmaceutical (RARE)
NASDAQ:RARE

Ultragenyx Pharmaceutical (RARE) Balance Sheet

570 Followers

Ultragenyx Pharmaceutical Balance Sheet

Ultragenyx Pharmaceutical's total assets for Q3 2023 were $1.24B, a decrease of -5.58% from the previous quarter. RARE total liabilities were $1.21B for the fiscal quarter, a 2.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 22Dec 21Dec 20Dec 19Dec 18
Total Assets
$ 1.55B$ 1.52B$ 1.76B$ 1.14B$ 719.56M
Total Liabilities
$ 1.19B$ 599.84M$ 605.18M$ 481.73M$ 110.65M
Total Equity Gross Minority
$ 352.49M$ 922.56M$ 1.15B$ 653.76M$ 608.91M
Total Capitalization
$ 352.49M$ 922.56M$ 1.15B$ 653.76M$ 608.91M
Preferred Stock Equity
-----
Capital Lease Obligations
--$ 48.23M$ 36.99M$ 0.00
Currency in USD

Ultragenyx Pharmaceutical Debt to Assets

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis